This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Feb;176(2):302-304.

doi: 10.1111/bjd.15297.

Severe systemic juvenile xanthogranuloma is an indication for systemic therapy

R Fölster-Holst¹

Affiliations

PMID: 28244093
DOI: 10.1111/bjd.15297

Comment

Severe systemic juvenile xanthogranuloma is an indication for systemic therapy

R Fölster-Holst. Br J Dermatol. 2017 Feb.

. 2017 Feb;176(2):302-304.

doi: 10.1111/bjd.15297.

Author

R Fölster-Holst¹

Affiliation

¹ Departments of Dermatology, Venereology and Allergology, University of Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.

PMID: 28244093
DOI: 10.1111/bjd.15297

No abstract available

PubMed Disclaimer

Comment on

Successful treatment of systemic juvenile xanthogranulomatosis with cytarabine and 2-chlorodeoxyadenosine: case report and review of the literature.
Maintz L, Wenzel J, Irnich M, Reinhard H, Bieber T. Maintz L, et al. Br J Dermatol. 2017 Feb;176(2):481-487. doi: 10.1111/bjd.14813. Epub 2016 Dec 2. Br J Dermatol. 2017. PMID: 27312940 Review.

Publication types

Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations